Richard Johnson

Richard Johnson M.D. is listed by Massinvestor as Managing Partner of the Mid Atlantic Fund, a Briarcliff Manor, New York venture fund and family office. The fund makes direct venture investments in healthcare and technology startups and also invests in other venture funds. Massinvestor lists the firm’s stage focus as early stage and says its direct startup investments range from about $100,000 to a few million dollars.

Johnson’s background is unusually operator-heavy for a venture investor. A 2011 BioSpace announcement described him as a life-sciences serial entrepreneur and venture capital investor with the Mid Atlantic Fund, with executive experience across marketing, corporate development, and operations in biopharmaceutical and healthcare-services companies. The same source says he had started seven life-sciences businesses, authored publications and patents, headed Hudson Global, founded AlveoLogic, co-founded QED Communications, and served as CEO of Vertos Medical, where he closed a Series C financing.

Earlier in his career, Johnson was CEO of Quintiles Commercialization North America, a group of Quintiles subsidiaries with more than $400 million in combined revenue, and held senior roles at Lederle Laboratories. He earned a bachelor’s degree from New York University, a medical degree from Mount Sinai School of Medicine, and completed Columbia University executive management training.

• Invests in seed and early-stage companies, especially where conventional VC check sizes may be too large and individual angel checks may be too small.
• Focuses on healthcare, life sciences, medical devices, and information technology.
• The Mid Atlantic Fund looks for healthcare and life-science technologies where it can “add value as advisors and managers.”
• The firm’s model includes both direct investments in startups and LP-style investments into relatively new or growing venture funds.
• Johnson’s own operating history suggests a bias toward companies where regulatory, clinical, commercialization, and healthcare-services execution experience matter.